Clinical trial for Point of Care STI Testing
Official title Point of Care STI Testing
ClinicalTrials.gov ID: NCT06844045
What this study is testing
- What it's testing
- The study wants to find out if quick, point‑of‑care STI testing is practical and acceptable, and whether it improves HIV testing and PrEP delivery for young people.
- Who it's for
- Adolescents who come to three pediatric clinics for STI testing.
- What's involved
- Participants receive a rapid STI test at the clinic instead of a standard lab test, along with HIV testing, counseling, and possible PrEP prescription, plus questionnaires about the process.
- Time commitment
- The study involves the clinic visit for the rapid test and follow‑up visits as needed, with the overall trial lasting the typical course of care.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 16 to 24
You may be able to join if
- \- Patients age 16-24 years receiving POCT or lab-based GC/CT testing
You likely can't join if
- \- Patients with known HIV or active PrEP prescriptions.
The study team makes the final eligibility decision.
Where it's taking place
- Philadelphia, Pennsylvania, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 16 years to 24 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Philadelphia, Pennsylvania, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.